Renaissance Technologies (RenTech)'s NVAX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 497,383 shares of Novavax, Inc. (NVAX) worth $4.05 M, representing 0.01% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in NVAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2022, adding 1.94 M shares. Largest reduction occurred in Q2 2023, reducing 3.1 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Novavax (NVAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novavax (NVAX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +497,383 | New Buy | 497,383 | $8.14 |
| Q4 2025 | -1.2 M | Sold Out | 0 | $0.00 |
| Q3 2025 | +529,103 | Add 79.25% | 1.2 M | $8.67 |
| Q2 2025 | +162,400 | Add 32.14% | 667,647 | $6.30 |
| Q1 2025 | -902,283 | Reduce 64.10% | 505,247 | $6.41 |
| Q4 2024 | -657,253 | Reduce 31.83% | 1.41 M | $8.04 |
| Q3 2024 | +954,600 | Add 85.99% | 2.06 M | $12.63 |
| Q2 2024 | +1.11 M | New Buy | 1.11 M | $12.66 |
| Q3 2023 | -438,883 | Sold Out | 0 | $0.00 |
| Q2 2023 | -3.1 M | Reduce 87.60% | 438,883 | $0.01 |
| Q1 2023 | +718,700 | Add 25.47% | 3.54 M | $0.01 |
| Q4 2022 | +1.94 M | Add 220.43% | 2.82 M | $0.01 |
| Q3 2022 | +880,583 | New Buy | 880,583 | $18.20 |
| Q2 2021 | -672,683 | Sold Out | 0 | $0.00 |
| Q1 2021 | +672,683 | New Buy | 672,683 | $181.31 |
| Q4 2020 | -208,583 | Sold Out | 0 | $0.00 |
| Q3 2020 | +208,583 | New Buy | 208,583 | $108.35 |
Renaissance Technologies (RenTech)'s Novavax Investment FAQs
Renaissance Technologies (RenTech) first purchased Novavax, Inc. (NVAX) in Q3 2020, acquiring 208,583 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Novavax, Inc. (NVAX) for 17 quarters since Q3 2020.
Renaissance Technologies (RenTech)'s largest addition to Novavax, Inc. (NVAX) was in Q4 2022, adding 2,821,683 shares worth $29,007.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 497,383 shares of Novavax, Inc. (NVAX), valued at approximately $4.05 M.
As of the Q1 2026 filing, Novavax, Inc. (NVAX) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Novavax, Inc. (NVAX) was 3,540,383 shares, as reported at the end of Q1 2023.